MTOR and neoplasm: Abnormal expression of PTEN leads to activation of the PI3K/AKT pathway, which up-regulates expression of mTOR, promotes proliferation of tumour cells, inhibits cell apoptosis and mediates multi-drug resistance of cells through PTEN/PI3K/AKT/mTOR [22].